Hydrocephalus and its implications for diagnostics, treatment and prognosis of patients with craniopharyngioma - a narrative review
Frontiers in Endocrinology · 12.11.2026 · 17
DOI: 10.3389/fendo.2026.2000937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, online erschienen am 12.11.2026. Verfasst von Hermann L. Müller. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Hydrocephalus is a clinically important complication of craniopharyngioma, but its relationship to treatment selection and long-term outcomes remains incompletely defined. This structured narrative review summarizes its reported frequency, diagnostic assessment, management, and associations with survival and functional outcomes.
Methods
A literature search of MEDLINE, Embase, PsycINFO, Web of Science, and Scopus identified 1,254 records. After screening, 49 articles published between 1990 and 2026 were included. Twenty-two publications examined associations between hydrocephalus and prognosis or outcome; 27 primarily reported its frequency or clinical management. Because study populations, definitions, and reporting methods were heterogeneous, findings were synthesized narratively without meta-analysis or formal risk-of-bias scoring.
Results
Reported hydrocephalus rates varied substantially (median 38%, range 8–81%). Hydrocephalus was associated in several cohorts with neurological morbidity and adverse neurocognitive outcomes, but the strongest pediatric cohort analysis found no independent association between initial hydrocephalus and overall survival, progression-free survival, or functional capacity. In contrast, hypothalamic involvement was strongly associated with long-term outcome. One mixed-age cohort did identify hydrocephalus as a risk factor for excess mortality, underscoring that the evidence is not uniform.
Conclusions
Hydrocephalus should be interpreted as both an urgent clinical condition and a potential marker of tumor anatomy and disease severity. Management requires distinguishing obstructive from communicating hydrocephalus, controlling intracranial pressure when indicated, and planning tumor treatment to preserve hypothalamic and neurological function. Current heterogeneous observational evidence does not establish hydrocephalus as a universal independent prognostic factor.
Zitieren
APA
Müller, H. L. (2026). Hydrocephalus and its implications for diagnostics, treatment and prognosis of patients with craniopharyngioma - a narrative review. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.2000937
Vancouver
Müller HL. Hydrocephalus and its implications for diagnostics, treatment and prognosis of patients with craniopharyngioma - a narrative review. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.2000937
BibTeX
@article{Mller2026,
author = {Müller, Hermann L.},
title = {Hydrocephalus and its implications for diagnostics, treatment and prognosis of patients with craniopharyngioma - a narrative review},
journal = {Frontiers in Endocrinology},
year = {2026},
volume = {17},
doi = {10.3389/fendo.2026.2000937}
}
EUVIMED